Liver Transplantation and Bariatric Surgery: Timing and Outcomes
Tayyab S. Diwan, Teresa C. Rice, Julie K. Heimbach, Daniel P. Schauer – 6 August 2018 – Nonalcoholic steatohepatitis (NASH) is projected to become the leading indication for liver transplantation (LT) in the next decade in the United States. Strategies to treat the underlying etiology of NASH, which is almost always obesity, are being pursued. One such strategy is the utilization of bariatric surgery (BS) in the peritransplant period. The use of BS prior to LT could prevent the progression of NASH and abrogate the need for LT.